LifeMine Therapeutics

Cambridge, United States

LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.

Mar 2022

Series C

Biotechnology Genetics Life Science Therapeutics

Top Investors

ARCH Venture PartnersForesite CapitalMerckFidelityGoogle Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about LifeMine Therapeutics

Who are LifeMine Therapeutics's investors?

LifeMine Therapeutics's investors include ARCH Venture Partners, Foresite Capital, Merck, Fidelity, Google Ventures.

Where is LifeMine Therapeutics headquartered?

LifeMine Therapeutics is headquartered in Cambridge, United States.

What does LifeMine Therapeutics do?

LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.

What stage is LifeMine Therapeutics at?

LifeMine Therapeutics is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 23, 2022.

MLA

"LifeMine Therapeutics — Funding & Investors." VCBacked, March 23, 2022, https://www.vcbacked.co/company/lifemine-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). LifeMine Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/lifemine-therapeutics

Wikipedia (cite web)

{{cite web |title=LifeMine Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lifemine-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 23, 2022.